MedPath

Virtual Reality Intervention for Skill Acquisition Support in Autism Spectrum Disorder (ASD)

Phase 2
Completed
Conditions
Autism Spectrum Disorder
Interventions
Device: Floreo VR Building Social Connections
Device: Sham
Registration Number
NCT05791071
Lead Sponsor
Floreo, Inc.
Brief Summary

A Randomized Controlled Phase II study to assess the efficacy of Floreo VR (Virtual reality) Building Social Connections as treatment for social skills in children with Autism Spectrum Disorder (ASD)

Detailed Description

In this randomized controlled phase II study, 30 eligible subjects aged 4-10 years old with documented ASD diagnoses will be enrolled and randomized in a 1:1 ratio intervention vs control group.

The Floreo VR Building Social Connections intervention is designed to be administered for 12 weeks, with three treatment visits per week, for a total of 36 treatment visits.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
30
Inclusion Criteria
  • Males and females aged 4 years to 10 years 11 months of age (up to 11th birthday at randomization).
  • Patients or legally authorized representatives must provide written informed consent and be willing and able to comply with study procedures. Participants must provide informed assent as clinically appropriate.
  • A diagnosis of autism spectrum disorder on the basis of the clinical judgement of a qualified clinician according to DSM-5 criteria, supported by either the Autism Diagnostic Observation Schedule or the Autism Diagnostic Interview-Revised.
  • Participants must receive ABA therapy at Cortica, with scheduled ABA sessions in clinic at least 3 times per week.
  • Participants must be able to tolerate VR therapy in the judgement of parent or caregiver and study staff
Exclusion Criteria
  • A history of photosensitive epilepsy, or photoparoxysmal response on electroencephalogram (EEG)
  • Active diagnosis of migraine headache or migraine variant (abdominal migraine, cyclic vomiting syndrome), not adequately controlled
  • History of balance disorder including vertigo, motion sensitivity, or balance disorder
  • Primary sensory impairment (blindness, deafness)
  • Motor disorder that would interfere with VR engagement

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Floreo VR Building Social ConnectionsFloreo VR Building Social ConnectionsParticipants will receive Floreo VR Building Social Connections lessons approximately 3 times a week for no more than 15 minutes per session.
ShamShamParticipants will receive non-interventional active VR videos approximately 3 times a week for no more than 15 minutes per session.
Primary Outcome Measures
NameTimeMethod
Autism Impact Measure (AIM) AssessmentThe AIM takes approximately 30 minutes to complete.

The AIM is a 25-item parent questionnaire targeting sensitivity to change of core ASD symptoms. The questionnaire uses a 2-week recall period with items rated on two corresponding 5-point scales (frequency and impact). The items cover distinct sub-domains of ASD symptoms including Repetitive Behavior, Atypical Behavior, Social Reciprocity, and Peer Interaction. A composite score is also calculated.

Secondary Outcome Measures
NameTimeMethod
CARS-2The CARS-3 takes approximately 5-10 minutes to complete after the information needed to make the ratings is collected

The CARS-2 is a 15-item rating scale used to identify children with autism and determine overall symptom severity. The scale is completed by a clinician familiar with the assessment of ASD after collecting information by direct interview and observation. The rater will also make use of supplemental collected using an unscored Parent/Caregiver Questionnaire. Only the CARS-2 Standard rating scale will be used for the purposes of this study.

Trial Locations

Locations (1)

Cortica

🇺🇸

Thousand Oaks, California, United States

© Copyright 2025. All Rights Reserved by MedPath